Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Hiroyuki Takamatsu, MD PhD, Shohei Mizuno, MD PhD, Tsutomu Takahashi, MD PhD, Shin-Ichi Fuchida, MD PhD, Ichiro Hanamura, MD PhD, Fumihiko Nakamura, MD PhD, Takehiko Mori, MD PhD, Yuta Katayama, MD PhD, Noriko Doki, MD PhD, Nobuhiro Tsukada, MD PhD, Tatsuo Ichinohe, Yoshinobu Kanda, MD PhD, Yoshiko Atsuta, MD PhD, Kazutaka Sunami, MD PhD

Blood (2019) 134 (Supplement_1): 4358.

https://doi.org/10.1182/blood-2019-123607

Published: 2019

Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5242.

https://doi.org/10.1182/blood-2019-124597

Published: 2019

Journal Articles

The Prognostic Value of IgH Clonality in Bone Marrow with Negative Pathology in B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Ayato Tsukamoto, MD PhD, Sho Yamazaki, MD PhD, Fumihiko Nakamura, MD PhD, Mineo Kurokawa, MD PhD

Blood (2018) 132 (Supplement 1): 5298.

https://doi.org/10.1182/blood-2018-99-114628

Published: 2018

Journal Articles

Intravenous Bortezomib Plus Dexamethasone Exhibits Similar Therapeutic Response As Subcutaneous Bortezomib-Based Triple Drug Regimen in Newly-Diagnosed Multiple Myeloma

Kiyomi Morita, MD, Junji Koya, MD, PhD, Takashi Toya, MD, PhD, Fumihiko Nakamura, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 5687.

https://doi.org/10.1182/blood.V128.22.5687.5687

Published: 2016

Journal Articles

Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma: Analysis of Incidence and Prognostic Factors

Masahiro Uni, MD, Yuki Kagoya, MD PhD, Yasuhito Nannya, MD PhD, Fumihiko Nakamura, MD PhD, Mineo Kurokawa, MD PhD

Blood (2014) 124 (21): 1666.

https://doi.org/10.1182/blood.V124.21.1666.1666

Published: 2014

Journal Articles

A Randomized Controlled Study Evaluating The Efficacy Of Aprepitant For Highly Emetogenic Chemotherapies In Hematological Malignancies

Ryo Nasu, Dr, Yasuhito Nannya, MD, PhD, Akihide Yoshimi, MD, PhD, Masataka Hosoi, M.D., Ph.D., Kouki Ueda, MD, PhD, Yumiko Yoshiki, MD, PhD, Shunya Arai, MD, PhD, Akihito Shinohara, M.D., Ph.D., Fumihiko Nakamura, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 1790.

https://doi.org/10.1182/blood.V122.21.1790.1790

Published: 2013

Journal Articles

High-Resolution Analyses of Genetic and Epigenetic Aberrations in Infant Leukemia with MLL Rearrangement.

Junko Takita, MD, PhD, Motohiro Kato, MD, Fumihiko Nakamura, MD, PhD, Yuyan Chen, MD, PhD, Go Yamamoto, MD, PhD, Yasuhito Nannya, MD, PhD, Masashi Sanada, MD, PhD, Tmohiko Taki, MD, PhD, Akira Kikuchi, MD, PhD, Takashi Igarashi, MD, PhD, Yasuhide Hayashi, MD, PhD, Seishi Ogawa, MD, PhD

Blood (2007) 110 (11): 4238.

https://doi.org/10.1182/blood.V110.11.4238.4238

Published: 2007

NARROW

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

The Prognostic Value of IgH Clonality in Bone Marrow with Negative Pathology in B Cell Lymphoma

Intravenous Bortezomib Plus Dexamethasone Exhibits Similar Therapeutic Response As Subcutaneous Bortezomib-Based Triple Drug Regimen in Newly-Diagnosed Multiple Myeloma

Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma: Analysis of Incidence and Prognostic Factors

A Randomized Controlled Study Evaluating The Efficacy Of Aprepitant For Highly Emetogenic Chemotherapies In Hematological Malignancies

High-Resolution Analyses of Genetic and Epigenetic Aberrations in Infant Leukemia with MLL Rearrangement.

Email alerts

ASH Publications

American Society of Hematology

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

The Prognostic Value of IgH Clonality in Bone Marrow with Negative Pathology in B Cell Lymphoma

Intravenous Bortezomib Plus Dexamethasone Exhibits Similar Therapeutic Response As Subcutaneous Bortezomib-Based Triple Drug Regimen in Newly-Diagnosed Multiple Myeloma

Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma: Analysis of Incidence and Prognostic Factors

A Randomized Controlled Study Evaluating The Efficacy Of Aprepitant For Highly Emetogenic Chemotherapies In Hematological Malignancies

High-Resolution Analyses of Genetic and Epigenetic Aberrations in Infant Leukemia with MLL Rearrangement.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only